Relebactam is a diazabicyclooctane beta-lactamase inhibitor, structurally similar to avibactam, and serves as an active pharmaceutical ingredient used in combination with imipenem and cilastatin. It features a piperidine ring that imparts a positive charge, reducing bacterial export, and was approved by the FDA in 2019 as part of the Recarbrio® combination product for treating complicated urinary tract infections, pyelonephritis, and complicated intra-abdominal infections in adults.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1174018-99-5
Relebactam
beta-lactamase inhibitor
Potassium clavulanate
beta-lactamase inhibitor active pharmaceutical ingredient
Cefditoren pivoxil
prodrug antibacterial active pharmaceutical ingredient
Calcium dobesilate monohydrate
Vasoprotective agent
Desethanol Dipyridamole
active pharmaceutical ingredient impurity
Desosaminylazithromycin
antibiotic pharmaceutical intermediate
1,1-Dimethylethyl 4-[[[(1R,2S,5R)-6-hydroxy-7-oxo-1,6-diazabicyclo[3.2.1]oct-2-yl]carbonyl]amino]-1-piperidinecarboxylate
research compound
[(2S,5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate
SMOBCLHAZXOKDQ-ZJUUUORDSA-N
C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)O)C(=O)NC3CCNCC3